Cost-effectiveness analysis comparing "PARP inhibitors-for-all" to the biomarker-directed use of PARP inhibitor maintenance therapy for newly diagnosed advanced stage ovarian cancer
| Image |  |
|---|---|
| Description | scientific article published on 27 August 2020 |
| Author/s |
author: Joseph A Dottino Andrew Berchuck |
| Publication date | August 27, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |